Compare NKTR & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTR | LZB |
|---|---|---|
| Founded | 1990 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1996 | 1994 |
| Metric | NKTR | LZB |
|---|---|---|
| Price | $36.98 | $29.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 2 |
| Target Price | ★ $133.08 | $41.00 |
| AVG Volume (30 Days) | ★ 1.4M | 534.4K |
| Earning Date | 11-05-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | N/A | ★ 5.11 |
| EPS | N/A | ★ N/A |
| Revenue | $307,711,000.00 | ★ $2,349,433,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.00 | $3.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $33.40 | $28.39 |
| 52 Week High | $109.00 | $44.90 |
| Indicator | NKTR | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 29.12 | 46.72 |
| Support Level | $34.45 | $28.79 |
| Resistance Level | $39.59 | $30.84 |
| Average True Range (ATR) | 1.98 | 0.76 |
| MACD | 0.66 | 0.19 |
| Stochastic Oscillator | 22.11 | 56.53 |
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.